Evidence map›Paper›PMID 40735479›Full record

ArticleFrontiers in pharmacology2025

The phenology of

Olha Mykhailenko, Banaz Jalil, Kateryna Uminska, Liudas Ivanauskas, Zigmantas Gudžinskas, Michael Heinrich

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Qualitative and quantitative standardisation ofPharmaceutical science advances · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Olha MykhailenkoPharmacognosy and Phytotherapy Group, UCL School of Pharmacy, London, United Kingdom.
Banaz JalilPharmacognosy and Phytotherapy Group, UCL School of Pharmacy, London, United Kingdom.
Kateryna UminskaZhytomyr Basic Pharmaceutical Professional College, Zhytomyr, Ukraine.
Liudas IvanauskasDepartment of Analytical and Toxicological Chemistry, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Zigmantas GudžinskasState Scientific Research Institute Nature Research Centre, Laboratory of Flora and Geobotany, Vilnius, Lithuania.
Michael HeinrichPharmacognosy and Phytotherapy Group, UCL School of Pharmacy, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: The phytochemical variability of Results: Among the hydroxycinnamic acids, chlorogenic acid was dominant in samples from shaded habitats, with maximum accumulation in samples from leaves during the vegetative phase (up to 2.25 mg/g DW). Flavonoids such as isoquercitrin and hyperoside peaked in leaves from the lake shore and wet grassland habitats during flowering. Oenothein B, a major ellagitannin, showed the highest concentrations in wet grassland leaves during flowering (73.97 mg/g DW). Conclusion: This study is the first to integrate habitat, phenology, and plant part data to characterise seasonal dynamics of key marker compounds in

Indexed as

Epilobium hirsutumHPLCHPTLCindustrial cropsmarker compoundsphenolic compoundsphenologyphytochemical variability

Identifiers

PMID40735479
PMCPMC12305433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.